Biography

Ranjit Manchanda is a Professor at Wolfson Institute of Preventive Medicine, Barts CRUK Cancer Centre, QMUL, and Consultant Gynaecological Oncologist at Barts and the Royal London Hospital, London, UK.

Ranjit’s research interests are focused around Targeted Precision Prevention. This includes population-based germline testing, mainstreaming genetic testing and precision medicine approaches for risk prediction, stratification, and targeted screening & cancer prevention. He has a keen research interest in health economic issues related to his areas of research. He is the Principal Investigator on the PROTECTOR trial, PROMISE Pilot study, GCaPPS trial, RRESDO, SIGNPOST, DETECT and UKCOGS studies.
He was awarded an NHS Innovation Accelerator (NIA) Fellowship for Population Genetic Testing (2019). He is a recipient of the RCOG Blair Bell award (2018) for research in population testing and the Dr Shyam Agarwal Memorial Oration award (2019) for contribution to cancer genetics. He has also received the Helen Harris Memorial Trust travelling Fellowship and NIHR Clinical Lecturer Fellowship awards.
He is co-Lead for the Cancer Prevention Theme at the Barts CRUK Cancer Centre. He is the Specialty Research Lead for Gynaecological Cancer, NIHR North Thames Clinical Research Network (CRN). He leads the high-risk women’s Precision Prevention Clinic at Barts Health and is chair of the London Cancer High risk Gynaecological Cancer MDT. He is a member of the NCRI Ovarian Cancer Surgical Sub group and has a keen interest in ultra-radical debulking surgery for ovarian cancer. He is a member of number of other advisory bodies and oversight committees.
He is the Integrated Academic Training Programme Director, London Specialty School of Obstetrics & Gynaecology, Health Education England, & Lead for the RCOG Advanced Professional Module (APM) in Clinical Research for London. He is a member of number of committees related to research and training. He has led a number of training initiatives in Gynaecological Oncology across Europe.
He has served as President of the European Network of Young Gynaecological Oncologists (ENYGO) and member of the European Society of Gynaecological Oncology (ESGO) Council from 2011-2013.